NextCure Inc (NXTC)
1.69
+0.11
(+6.96%)
USD |
NASDAQ |
May 09, 16:00
1.69
0.00 (0.00%)
After-Hours: 19:50
NextCure Free Cash Flow (Quarterly): -12.64M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -12.64M |
December 31, 2023 | -10.68M |
September 30, 2023 | -13.06M |
June 30, 2023 | -15.03M |
March 31, 2023 | -15.03M |
December 31, 2022 | -9.814M |
September 30, 2022 | -15.53M |
June 30, 2022 | -14.90M |
March 31, 2022 | -15.75M |
December 31, 2021 | -14.31M |
September 30, 2021 | -13.22M |
June 30, 2021 | -17.44M |
March 31, 2021 | -14.68M |
Date | Value |
---|---|
December 31, 2020 | -7.258M |
September 30, 2020 | -17.55M |
June 30, 2020 | -15.24M |
March 31, 2020 | -12.04M |
December 31, 2019 | -10.80M |
September 30, 2019 | -8.437M |
June 30, 2019 | -11.74M |
March 31, 2019 | -8.015M |
December 31, 2018 | 20.57M |
September 30, 2018 | -5.025M |
June 30, 2018 | -5.345M |
March 31, 2018 | -5.268M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-17.55M
Minimum
Sep 2020
-7.258M
Maximum
Dec 2020
-13.26M
Average
-13.77M
Median
Free Cash Flow (Quarterly) Benchmarks
Assertio Holdings Inc | 5.607M |
DiaMedica Therapeutics Inc | -3.815M |
Terns Pharmaceuticals Inc | -19.36M |
NovaBay Pharmaceuticals Inc | -0.316M |
Palatin Technologies Inc | -10.51M |